NCT01654640View on ClinicalTrials.gov

The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine

PHASE4TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Schizophrenia
Interventions
DRUG

Metformin

metformin 500mg p.o. bid for 24 weeks

DRUG

Placebo (for metformin)

placebo 1T bid

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01654640 - The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine | Biotech Hunter | Biotech Hunter